RUNX1 | Runt-related transcription factor 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Mixed |
SDC4 | Syndecan 4 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Expressed in all |
SEPT5 | Septin 5 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
SET | SET nuclear proto-oncogene | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SFPQ | Splicing factor proline/glutamine-rich | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
SLC34A2 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 2 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC45A3 | Solute carrier family 45, member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SPECC1 | Sperm antigen with calponin homology and coiled-coil domains 1 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
SRGAP3 | SLIT-ROBO Rho GTPase activating protein 3 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
SRSF3 | Serine/arginine-rich splicing factor 3 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SS18 | Synovial sarcoma translocation, chromosome 18 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
SSX1 | Synovial sarcoma, X breakpoint 1 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
SSX2 | Synovial sarcoma, X breakpoint 2 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
SSX2B | Synovial sarcoma, X breakpoint 2B | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
SYK | Spleen tyrosine kinase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Mixed |
TAF15 | TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
TCF3 | Transcription factor 3 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
TCF7L2 | Transcription factor 7-like 2 (T-cell specific, HMG-box) | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
TCL1A | T-cell leukemia/lymphoma 1A | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
TET1 | Tet methylcytosine dioxygenase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Mixed |
THRAP3 | Thyroid hormone receptor associated protein 3 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
TMPRSS2 | Transmembrane protease, serine 2 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
TOP1 | Topoisomerase (DNA) I | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
TP53 | Tumor protein p53 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transcription factors Transporters
| | | | | Expressed in all |
TPR | Translocated promoter region, nuclear basket protein | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
TRIM27 | Tripartite motif containing 27 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
TRIM33 | Tripartite motif containing 33 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
VTI1A | Vesicle transport through interaction with t-SNAREs 1A | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
WHSC1 | Wolf-Hirschhorn syndrome candidate 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
WWTR1 | WW domain containing transcription regulator 1 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
YWHAE | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon | Cancer-related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ZBTB16 | Zinc finger and BTB domain containing 16 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
ZCCHC8 | Zinc finger, CCHC domain containing 8 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
ZNF384 | Zinc finger protein 384 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
ZNF521 | Zinc finger protein 521 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Mixed |